Revolution Medicines Shares Drop on Clinical Data Update
On Monday, Revolution Medicines, Inc. (NASDAQ:RVMD) stock declined 10% following an update on clinical data. The company, focused on developing therapies for RAS-addicted cancers,...
On Monday, Revolution Medicines, Inc. (NASDAQ:RVMD) stock declined 10% following an update on clinical data. The company, focused on developing therapies for RAS-addicted cancers,...
By Daniel Wiessner (Reuters) - Apple (NASDAQ:AAPL) has been accused in a new lawsuit of illegally monitoring its workers' personal devices and iCloud accounts while also barring...
On Monday, Morgan Stanley (NYSE:MS) reiterated its equal-weight rating on AT&T Inc. (NYSE:NYSE:T) with a price target of $19.00. The rating comes as AT&T prepares to host its...
On Monday, shares of casino operators with a presence in Macau saw varying movements after the region's government data for November was released. Las Vegas Sands (NYSE:LVS)...
(Reuters) - Wall Street giant JPMorgan Chase (NYSE:JPM)'s global chair of investment banking Jennifer Nason is set to leave the bank early next year after almost four decades,...
By Tim Hepher PARIS (Reuters) - Airbus deliveries rose sharply to more than 80 jets in November as the planemaker recovered momentum towards end-year targets after a downturn over...
By Toby Sterling AMSTERDAM (Reuters) -Computer chip equipment maker ASML (AS:ASML) said it does not expect new U.S. restrictions on semiconductor exports to China, announced on...
Monday's market has seen significant movements among various stocks, with mega-cap companies like Tesla Motors (NASDAQ:TSLA) and Facebook Inc (NASDAQ:META) experiencing notable...
Earnings season continues, and we're here to spotlight the companies expected to unveil their financial results in the upcoming trading day. Leading the charge are tech giants...
As traders approach another pivotal day for financial markets on Tuesday, December 3, 2024, a series of crucial decisions and economic data releases that could sway market...